The QualityStocks Daily Friday, June 17th, 2022

Today's Top 3 Investment Newsletters

SeriousTraders(FDBL) $0.0005 +100.00%

Schaeffer's(REV) $3.7300 +91.28%

QualityStocks(MREO) $1.3000 +62.50%

The QualityStocks Daily Stock List

Corbus Pharmaceuticals Holdings (CRBP)

MarketClub Analysis, MarketBeat, Wall Street Resources, Schaeffer's, StockOodles, The Street, BUYINS.NET, StockMarketWatch, Marketbeat.com, Wealth Insider Alert, QualityStocks, StreetInsider, Promotion Stock Secrets, Barchart, INO Market Report, Kiplinger Today, TraderPower, Wealth Daily, Investopedia, InvestorPlace, Market Intelligence Center Alert, Street Insider, Profit Confidential, TopStockAnalysts, AllPennyStocks, TopPennyStockMovers, Insider Wealth Alert, Shah's Insights & Indictments, Daily Trade Alert, Stock Gumshoe, Stock Market Watch and Trades Of The Day reported earlier on Corbus Pharmaceuticals Holdings (CRBP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) (FRA: 337) is a pharmaceutical firm which develops and markets various therapeutics to treat severe, chronic and rare fibrotic and inflammatory ailments.

Corbus Pharmaceuticals is based in Norwood, Massachusetts and was founded in 2009. The firm is part of the pharmaceutical manufacturing industry and offers its services in Australia, Europe, Israel and the United States. The Corbus Pharmaceuticals corporate family has 3 firms under it.

Corbus Pharmaceuticals Holdings has a collaboration with Kaken Pharmaceutical Co. Ltd to develop and market lenabasum in Japan and a licensing agreement with Jenrin Discovery for the development and commercialization of licensed products, including the company’s library of roughly 600 compounds and multiple pending and issued patent filings.

The firm’s lead product candidate, lenabasum is an oral endocannabinoid drug which has been designed to treat fibrotic and chronic inflammation processes. The synthetic drug candidate is currently in its phase 2b clinical trial to test for its effectiveness in treating cystic fibrosis and systemic lupus erythematosus as well as undergoing its phase 3 clinical trial for the treatment of skin-predominant diffuse cutaneous dermatomyositis and systemic sclerosis. Additionally, the firm is developing CRB-4001, a CB1 inverse agonist, for fibrotic diseases like nonalcoholic steatohepatitis.

The firm’s lenabasum candidate would be very beneficial to individuals suffering from inflammatory or fibrotic ailments, who need effective treatments. While the drug is yet to be approved for treatment, positive results from its clinical trials show that its well on its way.

Corbus Pharmaceuticals Holdings (CRBP), closed Friday's trading session at $0.3002, up 28.8412%, on 1,065,865 volume. The average volume for the last 3 months is 1.066M and the stock's 52-week low/high is $0.208/$2.16.

Sesen Bio (SESN)

InvestorPlace, MarketBeat, QualityStocks, StockMarketWatch, Schaeffer's, MarketClub Analysis, TradersPro, PoliticsAndMyPortfolio, TopPennyStockMovers, StreetInsider, Jason Bond and BUYINS.NET reported earlier on Sesen Bio (SESN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sesen Bio Inc. (NASDAQ: SESN) (FRA: PCBK) is a late-stage pharmaceutical firm which is engaged in the designing, engineering, development and commercialization of innovative protein-based therapeutics called TFPTs, for the treatment of cancer.

Sesen Bio Inc. serves consumers in the United States and has its headquarters in Cambridge, Massachusetts. The firm was founded on February 25, 2008 by K. Dane Wittrup, Casey T. Weaver. Gregory L. Verdine. K. Christopher Garcia and Reza Dana.

Sesen Bio was known as Eleven Biotherapeutics Inc. before changing its name in May 2018. The firm is party to an agreement with Leiden University Medical Center which involves the co-development of an imaging agent.

Sesen Bio Inc.’s lead product candidate is a targeted fusion protein that is locally administered known as Vicinium and is currently undergoing phase 3 clinical trials testing for its effectiveness in treating high-risk NMIBC (non-muscle invasive bladder cancer) in Canada and in the U.S. The firm also has VB6-845d, which has been developed for use in treating different types of EpCAM-positive solid tumors; Vicinium combined with a checkpoint inhibitor developed by AstraZeneca indicated for the treatment of squamous cell carcinoma of the neck and head as well as Vicinium in tandem with Durvalumab, which is currently undergoing phase 1 clinical trials for the treatment of high risk non-muscle invasive bladder cancer.

Sesen Bio Inc. recently announced that they’d submitted their Marketing Authorization Application to the European Medicines Agency for their Vicinium candidate. The European region is among the biggest regions with regard to unmet needs for patients suffering with NMIBC. The candidate demonstrated a strong benefit profile and if approved, would be the first product approved for NMIBC treatment in more than 2 decades. The drug would also benefit NMIBC patients and could help prevent the thousands of deaths that occur annually as a result of the disease.

Sesen Bio (SESN), closed Friday's trading session at $0.76, up 29.2078%, on 28,499,308 volume. The average volume for the last 3 months is 28.499M and the stock's 52-week low/high is $0.365/$6.04.

Mereo BioPharma Group (MREO)

StockMarketWatch, QualityStocks, MarketClub Analysis, BUYINS.NET, Real Pennies, TradersPro and MarketBeat reported earlier on Mereo BioPharma Group (MREO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Mereo BioPharma Group Plc (NASDAQ: MREO) (FRA: MAH0) is a clinical stage biopharmaceutical firm that is engaged in the acquisition, development and the commercialization of therapeutic treatments of various rare and oncological ailments, focusing on endocrine, respiratory and bone/musculoskeletal indications.

Mereo BioPharma Group has its headquarters in London, the United Kingdom and was founded in 2015. The firm serves consumers across the globe.

Mereo BioPharma Group Plc is part of the biotechnology research services industry and operates in the biotechnology industry in the healthcare sector.

Mereo BioPharma Group Plc’s product candidates include an aromatase inhibitor that was developed for the treatment of hypogonadotropic hypogonadism called BGS-649 or leflutrozole; a kinase inhibitor that recently concluded phase 2 clinical trials to treat severe exacerbations of chronic obstructive pulmonary disease called BCT-197 or acumapimod and an antibody immunoreceptor with ITIM and Ig domains called OMP-313M31 or etigilimab, which is currently undergoing phase 1b clinical trials for the treatment of tumors. The firm also develops OMP-305B83 or navicixizumab, which is currently in phase 1a clinical trials for the treatment of late line ovarian cancer as well as rare ailments product candidates such as MPH-966 or alvelestat, which is currently undergoing a phase 2 clinical trial evaluating its efficacy in treating Alpha-1 antitrypsin deficiency and BPS-804 or setrusumab, which is currently in phase 2b clinical trials for osteogenesis imperfecta treatment.

December 2020 saw Mereo BioPharma Group Plc finalize a license and collaboration agreement with Ultragenyx for its setrusumab candidate. This move could potentially make setrusumab the first approved therapy for osteogenesis imperfecta, which is a devastating and rare disease in both adults and children. If it does get approved, it would be the first therapy for OI which would greatly benefit the patients as well as the companies involved.

Mereo BioPharma Group (MREO), closed Friday's trading session at $1.3, up 62.5%, on 137,044,569 volume. The average volume for the last 3 months is 133.91M and the stock's 52-week low/high is $0.301/$3.37.

Indoor Harvest  Corp. (INQD)

QualityStocks, SmallCapVoice, InvestorPlace, MarketBeat, Cannabis Financial Network News, CFN Media Group, Stock Shock and Awe, Penny Stock General, OTPicks, Orbit Stocks, Fast Money Alerts, PennyPickAlerts and MassiveStockProfits reported earlier on Indoor Harvest  Corp. (INQD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Indoor Harvest  Corp. is a developer of personalized cannabis medicines. In addition, the Company is a provider of advanced cultivation technology, methods, and processes. Indoor Harvest provides the cannabis industry production platforms for Building Integrated Agriculture (BIA) production. Established in 2011, the Company has its corporate headquarters in Houston, Texas. It is now moving its base of operations and focus to the Boston, Massachusetts area to leverage what it believes to be an attractive environment for cannabis companies since Massachusetts has legalized medicinal and recreational cannabis.

Indoor Harvest has transitioned into a producer of cannabis for research and pharmaceutical development. The Company’s patent pending aeroponic methods allow for the production of chemically consistent, contaminate free cannabis, economically at scale.

Indoor Harvest’s Management is working to deploy its integrated aeroponic technology platform, on its own and with partners in the Boston area, to demonstrate and highlight the Company’s belief in the technology’s ability to considerably decrease operating costs while boosting yield and quality.

Indoor Harvest  Corp. (INQD), closed Friday's trading session at $0.0106, up 45.2055%, on 37,000,629 volume. The average volume for the last 3 months is 37.001M and the stock's 52-week low/high is $0.0037/$0.0341.

Clovis Oncology (CLVS)

MarketClub Analysis, InvestorPlace, Schaeffer's, The Street, MarketBeat, StreetInsider, Money Morning, StocksEarning, Marketbeat.com, Hit and Run Candle Sticks, BUYINS.NET, Barchart, StockMarketWatch, Market Intelligence Center Alert, Cabot Wealth, Zacks, INO.com Market Report, Daily Trade Alert, AllPennyStocks, QualityStocks, Rick Saddler, Street Insider, StreetAuthority Daily, GorillaTrades, InvestorsUnderground, TraderPower, BestChartNow, Trades Of The Day, Investment House, Investors Alley, Streetwise Reports, TopStockAnalysts, Kiplinger Today, WStreet Market Commentary, StockEarnings, Weekly Wizards, Wealth Insider Alert, ChartAdvisor, CrashTrade, Trading Concepts, InvestmentHouse, Greenbackers, The Best Newsletters, TradersPro, Pennystockmania, TopPennyStockMovers, Stock Gumshoe, Trader Prep and Dynamic Wealth Report reported earlier on Clovis Oncology (CLVS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Clovis Oncology Inc. (NASDAQ: CLVS) (FRA: C60) (ETR: C60) is a biopharmaceutical firm that is engaged in the acquisition, development and commercialization of anti-cancer agents.

The firm has its headquarters in Boulder, Colorado and was incorporated in 2009, on April 20th by Erle T. Mast, Patrick J. Mahaffy, Gillian C. Ivers-Read and Andrew R. Allen. The firm serves consumers in the European Union, the United States and internationally.

The company is party to license agreements with Bristol Myers Squibb Company, 3B pharmaceuticals GmbH, Advenchen Laboratories LLC, AstraZeneca UK Limited and Pfizer Inc. It is also part of a partnership agreement with Foundation Medicine Inc. It distributes its products primarily via distributors and specialty pharmacies to healthcare providers and patients.

The enterprise’s products include a peptide-targeted radionuclide therapy and imaging agent known as FAP-2286, which targets fibroblast activation proteins; and an investigational angiogenesis inhibitor dubbed lucitanib, which impedes PDGFRa/Ã (platelet-derived growth factor receptors alpha and beta), VEGFR 1-3 (vascular endothelial growth factor receptors 1 through 3) and FGFR 1-3 (fibroblast growth factor receptors 1 through 3). This is in addition to developing a small oral poly ADP-ribose polymerase molecule inhibitor known as rucaparib (Rubraca), for metastatic castration-resistant prostate cancer and recurrent epithelial fallopian tube, ovarian and primary peritoneal cancer.

The firm recently appointed a new board member who brings with her extensive expertise in oncology research and drug development. This welcome addition will support the company’s key strategic priorities as they focus on advancing their Rubraca candidate and may have a positive influence on the firm’s growth and attractiveness to investors.

Clovis Oncology (CLVS), closed Friday's trading session at $1.18, up 31.873%, on 19,474,581 volume. The average volume for the last 3 months is 18.815M and the stock's 52-week low/high is $0.581/$6.65.

Jupiter Wellness Inc. (JUPW)

QualityStocks, Tip.us, Stocks to Buy Now, SeriousTraders, NetworkNewsWire, InvestorBrandNetwork, SmallCapRelations, StockWireNews, StockStreetWire, Small Cap Firm, MarketClub Analysis, Fierce Analyst, Mega Stock Alerts and Broad Street reported earlier on Jupiter Wellness Inc. (JUPW), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jupiter Wellness Inc. (NASDAQ: JUPW) is a pharmaceutical firm that is engaged in the development of CBD-based medical therapeutics and wellness products.

The firm has its headquarters in Jupiter, Florida and was incorporated in 2018, on October 24th by Brian S. John. Prior to its name change, the firm was known as CBD Brands Inc. It serves consumers across the globe.

The company is committed to helping individuals derive all of the extensive mental and physical benefits of its products.

The enterprise's product pipeline comprises of a non-prescription lotion/lip balm dubbed JW-200, which has been developed to treat symptoms of cold sores; a prescription product developed to treat burns known as JW-101; a new topical formulation which contains aspartame and CBD which has been developed to treat actinic keratosis, dermatitis and eczema dubbed JW-100 (CaniDermRX). It is also involved in the manufacture, distribution and marketing of similar consumer products, including products for dermatological treatments of inflammation and pain under the CaniDermRX brand; a skin care lotion infused with CBD under the CaniSkin brand; and a CBD-infused sunscreen which is offered under the CaniSun brand. Other CaniSun brand products include mineral-based sunscreen lotions and SPF 30 lip balm.

The firm plans to submit its JW-100 formulation for approval as an Investigational New Drug by the FDA. The formulation is indicated for the treatment of eczema, which causes the skin to become itchy, red and dry. The success of this formulation will help patients with eczema and also encourage more investments into the firm.

Jupiter Wellness Inc. (JUPW), closed Friday's trading session at $0.8, up 31.4276%, on 4,702,542 volume. The average volume for the last 3 months is 4.7M and the stock's 52-week low/high is $0.6003/$4.93.

Lordstown Motors Corp. (RIDE)

Green Car Stocks, Schaeffer's, InvestorPlace, The Street, StocksEarning, QualityStocks, MarketBeat, MarketClub Analysis, Trades Of The Day, Daily Trade Alert, CNBC Breaking News, The Online Investor, Early Bird, Kiplinger Today, StreetInsider, BUYINS.NET, The Stock Dork and Cabot Wealth reported earlier on Lordstown Motors Corp. (RIDE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Although the electric vehicle industry is poised to experience significant growth over the next couple of decades as more people ditch their combustion engine cars for EVs, affordability remains a major problem. A majority of American families simply cannot afford to buy an electric vehicle, and a significant percentage of EV owners had to rely on government subsidies and incentives to buy their EVs.

With lithium ore prices on the rise, the supply chain in disarray and the computer chip shortage still continuing, EV production costs are only going higher. For electric vehicles to become as affordable as regular gas-powered vehicles in the near future, something drastic needs to be done.

The CEOs of several automakers believe that lifting the federal government cap on the number of zero-emission vehicles that qualify for a tax credit of up to $7,500 is a great way to start.

CEOs from Ford Motor, General Motors, Toyota Motor North America and Chrysler parent company Stellantis recently sent a joint letter to congressional leaders asking them to lift the federal government cap because it will encourage consumers to adopt electric cars and trucks. This cap phases out the federal tax credit once an automaker sells 200,000 plug-in EVs, meaning every battery EV they sell after they hit 200,000 vehicles sold won’t be eligible for a federal tax credit. The executives argue that the incentive is crucial for electric vehicle affordability, especially in the wake of rising production costs and the cost of living.

Getting rid of this federal cap will “incentivize consumer adoption” of electrified vehicles, the executives wrote. At the moment, only Tesla and General Motors have exceeded the cap for tax incentives. Other automakers are also expected to pass the threshold in the near future as they produce and unveil a suite of new electrified products.

Rather than a cap of 200,000 sales, the letter recommends a sunset date for the tax once the electric vehicle industry grows and matures. The next couple of years will be critical to the growth of the EV market, the letter notes, and America’s domestic policies should work to ensure the country becomes a global leader in the EV race.

The executives also state that the four companies they lead have pledged to spend more than $170 billion through the year 2030 on electric vehicle development, production and sales, including more than $20 billion in the United States in the near future.

As the big four do their part in accelerating EV penetration, smaller-sized companies such as Lordstown Motors Corp. (NASDAQ: RIDE) won’t be far behind as they also want a share of the pie.

Lordstown Motors Corp. (RIDE), closed Friday's trading session at $1.65, up 7.1429%, on 5,455,599 volume. The average volume for the last 3 months is 5.456M and the stock's 52-week low/high is $1.485/$11.875.

Edesa Biotech (EDSA)

QualityStocks, TradersPro, StockMarketWatch, MarketClub Analysis, BUYINS.NET, Schaeffer's, StocksEarning and MarketBeat reported earlier on Edesa Biotech (EDSA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Edesa Biotech Inc. (NASDAQ: EDSA) is a biopharmaceutical firm that is focused on the acquisition, development and commercialization of clinical-stage drugs for immune-related and inflammatory ailments.

The firm has its headquarters in Markham, Canada and was incorporated in 2007, on June 12th. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on consumers in Canada and the United States.

The company is party to a license agreement with NovImmune SA, which involves the development of monoclonal antibodies that target CXCL10 and TLR4. It is focused on developing drugs for illnesses with clear unmet medical needs by exploring new ways to treat these illnesses. This includes the use of alternatives to topical steroids, which may sometimes cause side-effects. The company is organized under the laws of British Columbia.

The enterprise’s product pipeline is comprised of a sPLA2 topical treatment dubbed EB01, which employs a non-steroidal mechanism of action. This formulation is undergoing phase II clinical trials testing its effectiveness in managing chronic allergic contact dermatitis. It also develops a monoclonal antibody dubbed EB05, which is in phase III trials evaluating its efficacy in treating acute respiratory distress syndrome in patients with coronavirus infections. Acute respiratory distress syndrome is a life-threatening form of respiratory failure that causes death in the majority of patients with the coronavirus.

The company recently announced its latest financial results, with its CEO saying that they remained focused on creating value for the firm’s shareholders through the advancement of its formulations.

Edesa Biotech (EDSA), closed Friday's trading session at $1.62, off by 1.8182%, on 83,882 volume. The average volume for the last 3 months is 83,882 and the stock's 52-week low/high is $1.55/$12.00.

Marinus Pharmaceuticals (MRNS)

MarketBeat, Schaeffer's, BUYINS.NET, StockMarketWatch, MarketClub Analysis, Marketbeat.com, StreetInsider, TraderPower, InvestorPlace, The Street, Barchart, PoliticsAndMyPortfolio, TradersPro, Wall Street Mover, StockEarnings, Streetwise Reports, Kiplinger Today, Jason Bond, TopPennyStockMovers, Investing Futures and Penny Stock Prodigy reported earlier on Marinus Pharmaceuticals (MRNS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Marinus Pharmaceuticals Inc. (NASDAQ: MRNS) (BMV: MRNS) (FRA: 61Y) (LON: 0JYL) is a pharmaceutical firm that is engaged in developing and commercializing products for patients who suffer from seizure disorders like rare genetic epilepsies.

The firm has its headquarters in Radnor, Pennsylvania and was incorporated in 2003, on August 14th by Kenneth R. Shaw, Vincent A. Pieribone, Harry H. Penner Jr. and Geoffrey E. Chaiken. It operates as part of the biotechnology industry in the healthcare sector. The firm serves consumers in the United States.

The company is party to a collaboration agreement with Orion Corporation. It is also party to a license agreement with CyDex Pharmaceuticals Inc. and Purdue Neuroscience Company.

The enterprise’s product pipeline is comprised of an oral suspension known as Ztalmy, which has been developed to treat seizures linked to cyclin-dependent kinase-like 5 deficiency disorder, for the pediatric and adult patient populations in chronic and acute care and in self-administered and in-patient settings. Its Ztalmy candidate acts at extra-synaptic and synaptic GABAA receptors, a target for its anxiolytic, antidepressant and anti-seizure potential. The enterprise is also developing a formulation known as ganaxolone, to help treat genetic epilepsy disorders like PCDH19-related epilepsy, as well as Lennox-Gestaut Syndrome, depressive disorders and tuberous sclerosis complex.

The firm recently announced its latest operational and financial results, with its CEO noting that they remained focused on advancing its clinical programs and growing its ganaxolone franchise in an effort to help patients living with rare epilepsies. This will not only benefit patients with these indications but also bolster the firm’s growth.

Marinus Pharmaceuticals (MRNS), closed Friday's trading session at $4.36, up 4.5564%, on 411,803 volume. The average volume for the last 3 months is 406,119 and the stock's 52-week low/high is $3.97/$19.83.

Eton Pharmaceuticals (ETON)

TradersPro, MarketBeat, StockMarketWatch, StreetInsider, StocksEarning, Schaeffer's, MarketClub Analysis and BUYINS.NET reported earlier on Eton Pharmaceuticals (ETON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is a specialty pharmaceutical firm that is engaged in the development and commercialization of pharmaceutical products for rare illnesses.

The firm has its headquarters in Deer Park, Illinois and was incorporated in April 2017. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm has two companies in its corporate family and serves consumers in the United States.

The company has a diversified pipeline of over ten product candidates in different stages of development, all designed with the goal of addressing unmet patient needs.

The enterprise’s product candidates include Zeneo hydrocortisone auto-injector; a dehydrated alcohol injection; a cysteine injection; an oral suspension to help treat partial on-set seizures dubbed Lamotrigine; and the Zonisamide oral suspension to treat partial on-set seizures. It also develops a preservative-free ophthalmic product dubbed Alaway Preservative Free, for the treatment of allergic conjunctivitis; a topiramate liquid formulation dubbed Eprontia; and a replacement therapy known as Alkindi Sprinkle, for adrenocortical insufficiency in kids aged 17 and below. The enterprise is also involved in the development of a ready-to-use formulation dubbed Rezipres, designed to treat hypotension which occurs in setting of anesthesia; and Carglumic Acid to help treat chronic and acute hyperammonemia caused by N-acetylglutamate synthase deficiency.

The firm recently announced its latest financial results, which show significant growth in its product sales. Its CEO noted that they remained focused on launching additional products and getting more of its formulations approved, which would not only benefit patients and consumers in need of these products but also bring in more revenues and investments into the firm.

Eton Pharmaceuticals (ETON), closed Friday's trading session at $2.93, up 1.0345%, on 79,194 volume. The average volume for the last 3 months is 79,194 and the stock's 52-week low/high is $2.5711/$6.72.

Iridex Corporation (IRIX)

SmarTrend Newsletters, InvestorPlace, TradersPro, MarketBeat, Money Morning, Schaeffer's, StreetAuthority Daily, The Street, Wall Street Resources, StockMarketWatch, Zacks, Insider Wealth Alert, TopStockAnalysts, QualityStocks, Trades Of The Day, MarketClub Analysis and Wealthpire Inc. reported earlier on Iridex Corporation (IRIX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Iridex Corporation (NASDAQ: IRIX) is an ophthalmic medical technology firm that is engaged in the provision of therapeutic-based laser systems, consumable instrumentation and delivery devices for the treatment of sight-threatening eye diseases.

The firm has its headquarters in Mountain View, California and was incorporated in February 1989 by James L. Donovan, David M. Buzawa, Theodore A. Boutacoff and Eduardo Arias. Prior to its name change in November 1995, the firm was known as Iris Medical Instruments Inc. It operates as part of the medical devices industry, under the healthcare sector. The firm serves consumers in the United States.

The enterprise’s products include its EndoProbe products which are used in vitrectomy procedures; G-Probe Illuminate, which are used in procedures for the treatment of refractory glaucoma; and G-Probe, used in procedures treating uncontrolled glaucoma. It also provides OcuLightGLx, OcuLight GL, OcuLightSLx, OcuLight SL and OcuLight TX, as well as laser photocoagulation systems, which are used in the treatment of retinal tears, macular holes, proliferative diabetic retinopathy and detachments. This is in addition to providing its Cyclo G6 laser system to help treat glaucoma; its IQ 577 and IQ532 laser photocoagulation systems, to help treat retinal illnesses like diabetic macular edema; a slit lamp adapter which enables physicians to use a slit lamp in treatment and diagnosis procedures; and its TxCell scanning laser delivery system, which enables physicians to conduct multi-spot pattern scanning.

The company’s Cyclo G6 platform recently received clearance that will allow it to be marketed and sold in China. This move will not only bring in additional revenues and investments into the company but also bolster its growth.

Iridex Corporation (IRIX), closed Friday's trading session at $2.73, up 1.1111%, on 32,275 volume. The average volume for the last 3 months is 32,275 and the stock's 52-week low/high is $2.68/$9.4585.

Tenaya Therapeutics (TNYA)

MarketBeat reported earlier on Tenaya Therapeutics (TNYA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tenaya Therapeutics Inc. (NASDAQ: TNYA) is a biotechnology firm that is focused on discovering, developing and delivering therapies for heart diseases.

The firm has its headquarters in South San Francisco, California and was incorporated in August 2016 by Eric Olson, Saptarsi Haldar, Sheng Ding, Bruce R. Conklin, Benoit G. Bruneau and Deepak Srivastava. It operates as part of the scientific research and development services industry, under the healthcare sector. The firm serves consumers in the United States.

The company delivers curative therapies which address the underlying drivers of heart disease. It is currently advancing product candidates from 3 product platforms; precision medicine, cellular regeneration and gene therapy.

The enterprise’s product pipeline is comprised of a small molecule inhibitor of HDAC61 (histone deacetylase 6) dubbed TN-301, for use in heart failure with gDCM (genetic dilated cardiomyopathy) and HFpEF (preserved ejection fraction). It also develops an AAV-based therapy known as TN-201 to address genetic hypertrophic cardiomyopathy brought about by MYBPC3 (haplo-insufficient myosin binding protein C3) gene mutations; and an AAV-based therapy dubbed TN-401, which has been designed to address gARVC (genetic arrhythmogenic right ventricular cardiomyopathy) brought about by plakophilin 2 gene mutations. In addition to this, the enterprise is involved in the development of an AAV-based approach dubbed the Reprogramming program, designed for cardiac regeneration.

The firm, whose TN-201 formulation was recently granted orphan drug designation in Europe, remains focused on the advancement of its clinical programs. This will not only bring in additional revenues into the firm but also help create shareholder value.

Tenaya Therapeutics (TNYA), closed Friday's trading session at $5.42, off by 0.367647%, on 138,701 volume. The average volume for the last 3 months is 136,825 and the stock's 52-week low/high is $4.736/$32.00.

The QualityStocks Company Corner

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

Russia’s invasion of Ukraine has had negative geopolitical consequences that will last for years. As countries around the world raced to place sanctions on Russia for its unprovoked invasion, it became pretty clear that the energy sector was bound to take a major hit. Russia, which is a major supplier of uranium, provides an estimated 35% of the world’s enriched uranium. In 2020, the Eastern-European country was the second-largest supplier of uranium to the United States, accounting for 16.5% of the country’s uranium imports and supplying about 23% of the uranium imports the nation needed to power its commercial reactors. Data from the World Nuclear Association also shows that Russia has the largest enrichment capacity in the globe at 43%, followed by China. However, in the wake of the Russia-Ukraine war, the American government is looking for ways to wean itself off of Russia’s uranium and beef up its domestic supply. The plan to enrich a lot more uranium domestically is likely to be a shot in the arm of local uranium mining entities such as Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) since the government is likely to gobble up all the yellow metal they can dig out of the earth.

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR),based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon‐free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

Energy Fuels Inc. (UUUU), closed Friday's trading session at $5.25, up 0.574713%, on 3,381,729 volume. The average volume for the last 3 months is 3.372M and the stock's 52-week low/high is $4.32/$11.39.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is actively testing advanced battery technology that can provide a range of 600-plus miles on a full charge. “Mullen is making significant strides toward producing vehicles that feature some of the longest ranges available in the EV space... Earlier this year, the company announced an update on its next-generation solid-state polymer battery technology, which is a significant advancement over today’s current lithium-ion batteries. ‘Mullen’s testing of solid-state polymer reveals the potential for a 15-kilowatt-hour battery pack that delivers over 600-plus miles of range and highlights an 18-minute DC fast charge, which can yield over 300 miles of range,’” a recent article reads. “Recognizing the importance of battery and range in the success of an EV, Mullen is also exploring other advanced battery technologies, including lithium-sulfur and lithium-iron-phosphate. The company is committed to doing whatever is necessary to deliver EV batteries that will surpass today’s existing lithium-ion technology and offer a host of benefits, such as increased efficiency, energy density and range, while also lowering the cost, weight, thermal and environmental risks.” To view the full article, visit http://ibn.fm/dID9D

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Friday's trading session at $1.32, up 5.6%, on 58,558,510 volume. The average volume for the last 3 months is 58.559M and the stock's 52-week low/high is $0.52/$15.90.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is positioning to meet growing demand as recent global events, such as the war in Ukraine, have created a stark wake up call, making it clear it is about time the global fertilizer industry adopted more sustainable fertilizer production and distribution methods. “With Russia being the world’s largest exporter of fertilizers, accounting for 23% of global ammonia exports and over 40% of the world’s potash supply, reality is slowly hitting the industry on its overreliance on this country for fertilizer,” reads a recent article. “As an enterprise focused on licensing, partnership and acquisition opportunities relating to energy-efficient technologies and sustainability, FuelPositive’s flagship product, a containerized green ammonia production system, has proven to be a viable alternative from environmental and cost-savings standpoints. FuelPositive’s green ammonia production system uses renewable energy to produce nitrogen from air and hydrogen from water to synthesize green ammonia using its patent-pending converter technology. In addition, the containerized nature of the system allows for the process to be decentralized, giving farmers the ability to economically produce, on-site, the amount of ammonia they need. Ultimately, this allows them to end supply chain dependence and fluctuations with an almost negligible carbon footprint.” To view the full article, visit https://ibn.fm/Rts1E

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Friday's trading session at $0.1223, up 2.8595%, on 115,963 volume. The average volume for the last 3 months is 115,963 and the stock's 52-week low/high is $0.09/$0.24.

Recent News

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF)

The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

  • Since the summer of 2021, the number of users with access to the Lightning Network has increased from approximately 100,000 to over 80 million
  • LQwD’s current channel count on the Lightning Network is 17 and connects countries worldwide
  • LQwD currently has active nodes spanning the US, Japan, England, Canada, France, Italy, Indonesia, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, and Ireland
  • Company executive Stephen Thompson wrote an article for Bitcoin Magazine expressing that Bitcoin (as a network) could be the additional layer of trust needed with the internet infrastructure today

Over the last 30 days, the Bitcoin Lightning Network (“LN”) has experienced an increase in channel capacity, despite the current decline and bear market being experienced by much of the cryptocurrency world. The current capacity is teetering at the 4,000 BTC mark, translating into a growth of over 5% across the last 30 days (https://ccw.fm/aupkG). Arcane Research’s The State of Lightning Volume 2 was released in April 2022 and used transactional data from the platform to support its findings. With the adoption of the Lightning Network platform quickly rising, the research indicated that the number of payments over the past year has doubled, and the value of the transactions has increased by about 400%. Comparing last summer (2021) to March 2022, it was determined that the number of users with access to the Lightning Network has increased from approximately 100,000 to 80 million, respectively (https://ccw.fm/tRIT2). LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a fintech company focused on creating enterprise-grade infrastructure to drive bitcoin adoption, has been scaling its capacity on the network to drive awareness and growth. The company’s flagship platform as a service (“PaaS”) offering, https://lqwd.tech/, was released in November 2021 in addition to the first company node on the Lightning Network – US-West. 

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.

Product

The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Friday's trading session at $0.109, up 5.4159%, on 24,416 volume. The average volume for the last 3 months is 24,416 and the stock's 52-week low/high is $0.0754/$0.694.

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

In the state of Pennsylvania, a movement led by former members of the military has declared that there is an urgent need to make psychedelics widely available as a treatment for conditions such as severe depression and PTSD. The available treatments for mental health often aren’t effective, leaving veterans grappling with side effects, including muscle spasms and cramps, weight gain, and addiction. Prior studies have found that military veterans have an elevated risk of developing depression, post-traumatic stress disorder and traumatic brain injuries. Research conducted in 2018 found that 23% of veterans exhibited PTSD symptoms. With psychedelics seeing a resurgence in mainstream popularity and scientific research, initial studies have found that psychedelic drugs have the potential to treat mental health conditions, with few side effects. It appears that novel treatments such as psychedelics and ketamine administered by companies such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are proving to be significantly more effective than traditional formulations for mental health, and as more of these compounds are approved, veterans stand a real chance of beating the PTSD and trauma they face as a result of their experiences on the battlefield.

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Friday's trading session at $0.048, up 13.2075%, on 54,700 volume. The average volume for the last 3 months is 54,700 and the stock's 52-week low/high is $0.0302/$0.315.

Recent News

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF).

EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF), Canada's Renewable Natural Gas (“RNG”) Infrastructure Platform, is combating climate change and helping communities contribute to a sustainable future. Incorporated in 2020, EverGen acquires, develops, builds, owns and operates a portfolio of RNG, waste to energy, and related infrastructure projects, with operating and development projects in BC, Alberta and Ontario – three of the four largest markets for RNG in Canada. EverGen has current visibility to produce over 1 million GJ of RNG annually, and over 2 million GJ annually with its near-term pipeline of identified growth projects. For more information, visit the company’s website at www.EvergenInfra.com. To schedule a one-on-one meeting, please contact your Roth representative. To view IBN’s virtual coverage of the Roth London Conference, visit https://ibn.fm/Roth2022London. EverGen (TSX.V: EVGN) (OTCQB: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, recently announced the acquisition of a 50% stake in Ontario’s Project Radius. The move catapults EverGen into a whole new stratosphere of growth as the leading RNG infrastructure platform in its domicile Canadian market. “The company is forging ahead, eying opportunities to expand its market presence both internationally and in Canada. Poised to become a leading player in the burgeoning RNG space, EverGen aims to deliver on its aggressive growth strategy,” a recent article reads. “Following the letter of intent to acquire a 67% interest in Alberta-based GrowTec that was announced in March, the company continues to eye compelling market opportunities to capitalize on the booming RNG market. EverGen entered into definitive agreements with Northeast Renewables LP to acquire a 50% interest in Ontario-based Project Radius for a cash contribution of $1.5 million. As a result, EverGen now boasts a unique market position as the leading RNG infrastructure platform in Canada, with a presence in three of the four largest Canadian jurisdictions with plans to expand further.” To view the full article, visit https://ibn.fm/VjWR2

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQB: EVGIF), closed Friday's trading session at $2.94, even for the day. The average volume for the last 3 months is 900 and the stock's 52-week low/high is $2.12/$4.21.

Recent News

AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF)

The QualityStocks Daily Newsletter would like to spotlight AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF).

Two members of Congress have revealed that high-level legislators are discussing putting together a package of cannabis proposals that could be enacted in a marijuana omnibus law this year. Furthermore, sources have revealed that these discussions cover a wide range of issues, not just the expungement and cannabis banking reforms that have been the crux of cannabis discussion in recent times. The two Congressmen revealed that the discussions involve incremental reform and comprehensive cannabis legalization. Those in the know say that these discussions have the potential to result in actionable, bipartisan cannabis policy, a feat that has eluded Congress for decades. Sources say legislators have discussed adding standalone language from cannabis bills that deal with issues such as research expansion, lack of veteran access to medical cannabis, drug-sentencing reform and granting the cannabis industry access to Small Business Administration (SBA) loan programs. It remains to be seen whether this new flurry of activity will result in any meaningful policy changes that ease the operations of companies such as Advanced Container Technologies Inc. (OTC: ACTX).

AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) is a fully integrated, publicly traded, early-stage life science enterprise dedicated to delivering therapeutic interventions to public health through discovery, innovation and successful collaborations in the life science industry. The company’s leadership drives discovery programs for clinical complexities presented by malnutrition, viral infectious diseases and the inflammatory response system.

AREV’s business model leverages the core competency of producing proprietary compounds through its innovative extraction methodologies, scientific advisory board (SAB), experienced staff, and executive leadership to drive its product pipeline. AREV’s strategy is to generate revenue from selling its branded products via its online technology platform, Medicine Merchant™, an enterprise marketing platform built to enable consumers to have access to novel therapeutic approaches to human nutrition, endemic diseases, and neglected chronic related co-morbidities. The company also expects to generate revenue from toll processing and government procurement of its products that address malnutrition and related health issues.

AREV is focused on innovations in biomedicine and maintains a significant footprint in clinical human nutrition utilizing proprietary protein blends and terpenes, complimented with vitamins and minerals. The company has utilized its expertise to design and deliver innovation in therapeutic interventions using its exclusive botanical, fungi and marine compounds to address medical conditions driven by presenting global epidemiological characteristics of multiple challenges to international human and animal health. AREV uses its proprietary extractions allowing characterizations from botanical and marine sources in therapeutic foods and medicines that comprise its development pipeline.

Development of AREV’s pipeline is fostered by collaborations with academic centers, clinical research organizations and government institutions committed to facilitating discovery of promising new clinical approaches presented in peer reviewed journals. AREV operates under the guidance of its SAB and a growing number of strategic collaborations with CROs and academic research centers, including the Linus Pauling Institute at Oregon State University.

AREV is a member of both BIOTECanada and The Biotechnology Industry Organization (BIO):

  • BIOTECanada is the national industry association with over 200 members located nationwide, reflecting the diverse nature of Canada’s health, industrial and agricultural biotechnology sectors.
  • BIO is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and 30+ countries.

Products

AREV’s end-product and target categories include therapeutic interventions, botanical drugs, ready-to-use therapeutic food (RUTF), enteral nutrition formulas and early-stage small molecule antiviral therapeutics demonstrating novel mechanisms of action.

Wright and Well Branded Line

Wright and Well Branded Line is the company’s branded line of therapeutic cannabinoid and terpene-based formulations. The topical line includes solutions for burns, wounds, skin disorders and muscle relief, as well as a lubricant for intimacy. The oral line addresses inflammation, heart health, high blood pressure and viral infections. These products are currently produced at CBD99, a licensed processor in Sandy, Oregon. The company also has a strategic relationship with a Canadian licensed hemp and cannabis processor in Vancouver, British Columbia.

SUS-TAINN™

The company’s products in the RUTF category are branded under SUS-TAINN™ (Superior Utility Supplementation Therapeutic Agent for Indicated Nutritional Needs). SUS-TAINN™ is the flagship line of products stemming from AREV’s collaboration with Voynich Biosciences.

RUTFs like SUS-TAINN™ are the cornerstone to international famine response and currently represent more than 20 percent of public health commodity procurement spending. SUS-TAINN™ is purchased by agencies ranging from the U.S. Department of State AID for International Development to the World Food Program and is distributed by an increasingly substantial number of non-governmental organizations.

RESTORE™

The company’s enteral nutrition product is branded as RESTORE™. For patients experiencing caloric compromise, enteral nutrition, a liquid form of nourishment, is often required. RESTORE™, the initial enteral formulation from AREV, is based on organic plant nutrition for patient populations who have demonstrated overt clinical need for rational enhanced caloric intake and micronutrient supplementation.

RESTORE™ provides a proprietary blend of high-quality proteins, antioxidants, minerals and proven anabolic agents, combined with pre- and probiotics. The company plans to submit for Medicaid formulary inclusion and reimbursement designations in various jurisdictions characterized by the Ryan White CARE Act during the second half of 2022.

REV-I1™

REV-I1™ is the company’s small molecule drug discovery model for phytomedicinalization, based on advanced computational characterization and next generation affinity selection that affords new opportunities in HIV antiretroviral research. REV inhibition offers a critical approach to inhibiting HIV replication and addressing viremia in highly conserved sanctuary regions.

Phytomedicinal therapeutic discovery and development offer clinically viable approaches to a wide range of scientific challenges that currently elude successful contemporary interventions. A cornucopia of diverse validated compounds allows AREV to explore a distinguished range of promising approaches that are in stages of pre-clinical validation. Combining AREV’s versatile extraction capability with highly sensitive analytical techniques (LC-MS, MS-MS) is expected to allow new medicinal chemistry to be identified and characterized, leading to therapeutic candidates in the company’s commercial drug discovery platform.

Market Overview

A report from Verified Market Research valued the global plant protein market at $29.4 billion in 2020 and forecast that it could surpass $162 billion by 2030, which would make up 7.7% of the global protein market, according to a report released in August by Bloomberg Intelligence.

The RUTF market was valued at $363.72 million in 2019 and is projected to reach $807.89 million by 2027, growing at a CAGR of 10.5% for the forecast period. The market is primarily driven by the efforts of governments and non-governmental organizations to reduce the rate of severe acute malnutrition. Moreover, changing trends and growing developments related to diet-related deficiencies, as well as increasing incidences of famine and disasters, are likely to fuel the growth of the RUTF market in the near future, according to the report.

Management Team

Michael Withrow is the founder, chairman and CEO of AREV. He is a successful natural products and technology entrepreneur with more than 25 years of experience. He has started and sold companies and has worked with companies such as CAVA Health Care (formerly Alternative Extracts Inc.), North American BioExtracts Inc., and Canadian Pacific Phytoplankton Ltd. He has also served as president and CEO of a specialty cannabis technology company.

Kevin Phelps, CPA, is a director at AREV. He is CEO and president of Immune Therapeutics Inc., a bio-pharmaceutical company. He began his career with Price Waterhouse before joining Eastman Kodak Company as part of an executive team that successfully spun out the Bio Products Division into Genencor International Inc., an international industrial bio-chemicals company. He later joined Trillium Group, a regional private equity firm, as a partner, where he served on behalf of the firm as CFO of Vaccinex Inc., a vaccine development company, and chairman of AccuMed Inc., a medical device company. He has served as Chairman of Oyagen, a biotech that over the past decade has developed drug discovery methods that have enabled it to explore vulnerabilities in HIV, Ebola and coronaviruses.

Denby Greenslade is corporate secretary and interim CFO at AREV. She has served as corporate secretary and director for several companies in the mining, biotech and IT industries and has more than 15 years of corporate secretarial, corporate governance, and securities regulation experience. She graduated from Simon Fraser University with a Bachelor of Arts in Communication.

Allan Echino is a director at AREV. He was a founder and director of Corlac Resources, an oil producer, and Calroc Industries, an oil service company based in Alberta. Mr. Echino arranged funding for a licensed producer in the cannabis sector and quickly learned the business and health benefits of cannabis and mushrooms.

Mel Maxwell is a director at AREV. During his 40-plus year career, he has founded six companies. His degrees in business and computer science initially took his career toward IT ventures that entailed software development, IT consulting, e-commerce solutions, real estate development, pathogen remediation solutions and wholesale vehicle aggregation. He finds continued enjoyment in consulting with other businesses and entrepreneurs.

Scientific Advisory Board

Roscoe M. Moore, Jr., DVM, MPH, PhD, a former United States Assistant Surgeon General, provides strategic planning for AREV’s nutritional and drug discovery platforms as chairman of the company’s scientific advisory board. Dr. Moore is a member of the board of advisers of the Institute of Human Virology (IHV) and the board of directors of the Global Virus Network associated with IHV, University of Maryland Medical Center. IHV is the first research institute in the U.S. to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments; its 80 faculty members contribute to research on pandemic pathogens, ranging from COVID-19 to HIV.

Dr. Moore served with the United States Department of Health and Human Services (HHS) and was responsible, for the last 12 years of his career, for global development support within the Office of the Secretary, HHS, with primary emphasis on implementing innovations in essential health care commodity procurement programs for resource-challenged countries. Dr. Moore was a career officer within the Commissioned Corps of the United States Public Health Service, entering with the U.S. National Institutes of Health (NIH) and rising to the rank of Rear Admiral. Dr. Moore worked at the Center for Veterinary Medicine, U.S. Food and Drug Administration (FDA), before becoming senior epidemiologist within the National Institute for Occupational Safety and Health of the U.S. Centers for Disease Control and Prevention (CDC), where he also served as an epidemic intelligence service officer.

Robert Melamede, PhD, received his doctorate in molecular genetics and biochemistry from the University of the City of New York Graduate Center, focusing on base excision repair of free radical damages in DNA. For decades, he led laboratory efforts in a world-class, federally funded lab, where he discovered endonuclease VIII. Dr. Melamede did a sabbatical at the Scripps Institute and subsequently established an in vitro monoclonal antibody facility at the University of Vermont, developing antibodies to free radical damages in DNA and to DNA repair enzymes. Working with a collaborator, Dr. Melamede worked on metabolism and cancer cells as a professor and chair of the biology department at the University of Colorado at Colorado Springs. He co-founded Cannabis Science Inc., a public company, retiring as the company’s chief executive in 2014. Dr. Melamede continues his innovative research in the private sector.

Harold Smith, PhD, is the founder, CEO, and president of Oyagen Inc., a biotechnology company developing therapeutics for various disease states, including HIV and cancer. Dr. Smith is also a tenured professor of biochemistry and biophysics at the University of Rochester, School of Dentistry and Medicine, with additional appointments as a professor in genetics and pathology and as a member of the Center for RNA Biology.

Richard Van Breemen, PhD, is a Professor of Medicinal Chemistry in the Department of Pharmaceutical Sciences of the College of Pharmacy at Oregon State University. His research interests include cancer prevention by dietary antioxidants and prostate cancer prevention by the carotenoid lycopene, mass spectrometry-based pharmacological screening of natural products and combinatorial libraries for drug discovery, and high throughput screening to assess drug metabolism, toxicity and bioavailability. Dr. Van Breemen made The Analytical Scientist’s Power List in 2020 and 2021. His work in biomedical mass spectrometry earned him an initial spot, and he clocked in the Top 100 analytical scientists from around the world on the Power List in 2021.

Dr. Blake Hawley is the founder & CEO of Motega Health Inc. Dr. Hawley has worked in animal health, pharma and food across 23 countries and four continents. He holds an MBA from KU and his doctorate in veterinary medicine and zoology degrees from NC State. He serves on multiple non-profit advisory boards, including the KU MBA Advisory Board. Dr. Hawley is a 2017 graduate of Pipeline Entrepreneurs and a graduate of the Village Capital Agricultural 2016 Entrepreneur Cohort.

Dr. Hawley previously served as the General Manager of Australasia; Regional General Manager of Russia and Central Eastern Europe (consisting of 22 countries); and Managing Director of the United Kingdom and Ireland for Hill’s Pet Nutrition, a division of Colgate-Palmolive. His experience includes 10 years of profit and loss responsibilities in these territories, with consistent double-digit annual revenue growth in each of the 10 years. He oversaw products competing in the arthritis, dermatology, obesity, gastrointestinal, urinary, and cancer markets, among others. Dr. Hawley also has background in e-commerce, data analytics, and social media and most recently served as Worldwide Director of Global Digital for Hill’s Pet Nutrition.

Uma Dhanabalan, MD, MPH, FAAFP, MRO, CMS, advises AREV on product development and formulation. She is the founder and CEO of Global Health & Hygiene Solutions LLC, whose mission is to promote wellness and prevent illness locally and globally and runs an independent practice at Uplifting Health & Wellness in Cambridge, Massachusetts. Dr. Dhanabalan, a fellow of the American Academy of Family Physicians, graduated from UMDNJ, Newark, New Jersey, with her medical degree and trained in family medicine at MUSC in Charleston, South Carolina; she earned her master’s degree in public health from Harvard’s School of Public Health in Boston, Massachusetts, and continued her training at Harvard in occupational and environmental medicine.

Special IP Advisor

Douglas Sorroco practices in all areas of intellectual property law including patent, trademark, copyright, technology, and e-commerce and assists clients with intellectual property matters requiring litigation, licensing, technology counselling and complex transactions.

Mr. Sorroco is ranked in Band 1 (the top band) for intellectual property law by the highly regarded Chambers USA: America’s Leading Lawyers for Business 2021, and he was selected for inclusion in The Best Lawyers in America® 2022 for Litigation – Intellectual Property, Litigation – Patent, Patent Law and Technology Law. In 2021, Best Lawyers named him the Oklahoma Lawyer of the Year for Technology Law. In 2021, Managing Intellectual Property continued to rank Doug as an IP Star. Mr. Sorroco was selected for inclusion in Oklahoma Super Lawyers 2021 and was also selected by attorney peers for inclusion in Oklahoma Super Lawyers – Rising Stars Edition (2010).

AREV Life Sciences Global Corp. (OTC: AREVF), closed Friday's trading session at $0.95, even for the day. The average volume for the last 3 months is 1,501 and the stock's 52-week low/high is $0.54/$3.50.

Recent News

Tingo Inc. (OTCQB: TMNA)

The QualityStocks Daily Newsletter would like to spotlight Tingo Inc. (TMNA).

Runaway climate change over the past decades has drawn the attention of the world, and global leaders have been scrambling to come up with measures to halt or even reverse some of the effects accelerating global warming. Grand promises have been made, but action is woefully inadequate as we head to the 2050 deadline to net-zero. However, blockchain technology can be leveraged to unlock the carbon market and scale the use of carbon credits in the fight against climate change. Currently, registries such as Gold Standard and Verra issue carbon credits to organizations and entities that can’t avoid generating greenhouse gases in their operations. The funds generated from the sale of those carbon credits are invested in projects that are ecologically friendly and absorb carbon from the atmosphere. There are nearly endless possibilities of where and how blockchain technology can be deployed, and entities such as Tingo Inc. (OTC: TMNA) are taking the lead in coming up with solutions that address the different needs of society.

Tingo Inc. (OTCQB: TMNA) is a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa. The company aims to be Africa’s leading agri-fintech player, transforming rural farming communities to connect through its proprietary platform to meet their complete needs – from inputs and agronomy to off take and marketplace – and deliver sustainable income in an impactful way. The company’s vision is to build complete digitally inclusive ecosystems that promote financial inclusion and deliver disruptive micro-finance solutions, empower societies, produce social upliftment in rural communities and open international opportunities.

Tingo believes that a truly connected world will help contribute to a better global society. The company’s core focus areas are telecoms, financial services/fintech and agritech. Tingo’s goal is to provide a best-in-class customer experience, support the domestic economies of its host countries and support technological and financial inclusion to end the poverty premium. Through this, Tingo hopes to deliver attractive returns to shareholders while investing in the long-term future of the company and its subsidiaries.

Global climate change is challenging sustainable production and food security. Tingo’s strategy and market execution provide an opportunity for Africa to be a core focal point to solve a number of key areas of concern, including food security, gender equality, financial inclusion and poverty alleviation, to name a few. Disruption of micro finance through the use of DeFi-based stable coins and smart contracts will give agri-communities access to capital markets-driven digital finance solutions that make them more competitive and sustainable economically, striking a good balance of returns between digital asset providers and Tingo as the service partner. This innovation will deliver significant access to much needed finance at ‘Grassroot’ levels, delivering tangible social upliftment and GDP growth in the African markets served by Tingo.

Tingo Mobile, with more than nine million subscribers, is Nigeria’s leading technology and device-as-a-service platform aimed at accelerating digital commerce, especially in the country’s agritech and fintech verticals. The company helps farmers acquire mobile phones through a unique leasing plan, connecting them to mobile and data networks through its own virtual mobile network. Tingo also connects farmers to markets, services and resources via Nwassa, its digital agritech marketplace platform that commenced operations in 2020. The company has also launched a beta version of TingoPay – a B2B and B2C fintech app aimed at providing financial services to users inside and outside of the agriculture value chain. Among the services offered are mobile wallets, payment processing and access to specialist lenders, insurers and pension products.

Tingo will soon announce its innovative blockchain-based solution for use of digital stable coins to empower frictionless trade across borders in Africa. The company’s market-proven model in Nigeria is its core foundation, enabling Tingo to deliver the same service model across Africa to become the continent’s leading agri-fintech business powered through smartphone technology.

The African Continental Free Trade (ACFT) plan will be a key framework to prepare the company to be the leading intra-Africa trading hub for trade flows across Africa in the medium term, when it is likely the agreement will be executed into tangible activity. Tingo is well positioned to easily transform the goals of the ACFT into reality when finally implemented by the African Union and the various African countries that have not signed up.

Tingo posted total revenue of $594 million in 2020, with $212 million EBITDA. As of December 31, 2020, Tingo has 9,344,000 subscribers. The company is confident that these figures will grow through its expansion across Africa and natural progression of business in Nigeria.

Businesses

Tingo has four core businesses:

  • Mobile Phone Leasing – Tingo has distributed almost 30 million mobile handsets since 2014 and will continue to replace the devices of its installed customer base every three years. Tingo Mobile provides the latest mobile phone handsets at an affordable price point and allows customers to spread payments over 36 months.
  • Mobile Voice and Data Service – Through a mobile virtual network, Tingo provides its customers with voice and data services, allowing customers to communicate effectively, both inside and outside the agricultural ecosystem.
  • Nwassa Marketplace Platform – Nwassa is Tingo’s proprietary agritech platform which provides Africa’s farmers with access to global markets to secure more competitive pricing for their crops. The platform processes 500,000 daily transactions with a value of over $8 million. A select group of trusted partners can assist smallholder farmers and agricultural cooperatives with packaging, warehousing, and dry and wet cargo logistics, as well as up-to-date information from the global agricultural sector. Tingo provides its customers with digital wallet services, which enable them to send and receive domestic payments, monitor cash flow in real time and securely hold money. The company also provides access to other services, such as utility bill payment, virtual airtime top-up, insurance services and alternative lending solutions.
  • TingoPay – Since the launch of the Nwassa platform, Tingo has been a dominant player in the B2B fintech vertical. After many successful months of operating Nwassa, Tingo entered the fintech B2C vertical to extend its B2B offering to a broader market beyond agriculture.

TingoPay is still in its beta phase and will launch in 2021 with a comprehensive marketing campaign. TingoPay offers the following services:

  • Tingo Wallet top-up
  • Peer to Peer payments, inclusive of merchant payments at the stores
  • Utility payments – airtime, broadband, cable, electricity, water, hotel, flights etc.
  • Pension payments
  • QR code payment services

Market Opportunity

Africa is the second-largest continent by population. It is also the youngest by far, with a median age of 18 for its 1.3 billion people. Tingo believes the building blocks for growth in Africa’s agriculture industry are in place and that the company is well positioned to participate in the upside. Sub-Saharan Africa’s population is growing at a rate of 2.7 percent per year. At the current growth rate, the continent’s population will double by 2050. Africa’s youthfulness represents a significant opportunity for material growth in demand for agricultural commodities. This younger generation is also being born into a digital world and is comfortable using technology.

Africa’s governments are improving business conditions for entrepreneurs and small businesses. Sub-Saharan Africa’s World Bank Doing Business rank has improved from 45 in 2004 to 65 in 2020. Tingo believes this trend will continue and encourage establishment of more new ventures across all economic sectors, including agriculture.

Africa attracted $407 billion of Foreign Direct Investments (“FDI”) between 2014 and 2018. Investments are increasingly focused on services and industrial sectors. Only 20 percent of investments are in extractive industries – a clear reversal from 2008, when 55 percent of FDI was aimed at resource extraction. Tingo believes FDI into Africa will help resolve significant infrastructure constraints and create value for agribusiness.

Management Team

Dozy Mmobuosi is the CEO of Tingo. He cofounded Tingo Mobile PLC (Nigeria) in 2001 and led the design and launch of Nigeria’s first SMS banking solution, which is still in use in the country today. He also headed a team of more than 120 Chinese and Nigerian engineers in the construction of two mobile phone assembly plants in Nigeria, which have produced and distributed 20 million phones across the country. He has led Tingo’s growth to more than $600 million in revenue annually. He holds a Ph.D. in Rural Advancement from UPM Malaysia.

Dakshesh Patel is the CFO of Tingo. He was formerly CFO of NatWest’s Global Debt and Investment Banking division. He has served as a Director at Gerken Capital Associates, a San Francisco-based alternative asset fund manager. He also led the restructure of Lloyds Banking Group (last financial crisis); managed integration of two leading shipping groups’ global treasury function to create world-leading shipping group Maersk Shipping; built three fintech companies; and exited one to Worldpay. Mr. Patel has strong banking experience, with a focus on Africa. He is a chartered accountant.

Chris Cleverly is president of Tingo. He has served as CEO of the Made in Africa Foundation, and as CEO of blockchain payments gateway startup Kamari. He has been a board member of several companies, both public and private, in the UK, India, China and Africa. He has advised multiple UK companies on their entrance into African markets, and regularly advises the UK Government on development issues and African governments on investment issues.

Clarence Simms is the Chief Technology Officer at Tingo. He has 25 years of IT and IT management experience. He has worked in IT Shared Services Technical Operations and IT Program Management for Huawei Technologies and MTN. As an entrepreneur, he created Africaprepay.com, a service that allows African Diaspora travelers to send airtime, pay bills, send mobile money and transfer money to a bank account from anyplace in the world.

Rory Bowen is the Chief of Staff at Tingo. Mr. Bowen started his career in traditional capital and derivatives markets working for Moneycorp and Tradition UK in European and emerging markets across FX, interest rate derivative and government bond markets. He has also spent time with one of Europe’s fastest growing fintech’s banking circles. Before joining Tingo, he was Chief of Staff at FinTech Alliance, an organization established in partnership with the UK Government Department for International Trade to foster innovation, growth and foreign direct investment (FDI) in the financial services sector and facilitate greater public/private cooperation.

Tingo Inc. (OTCQB: TMNA), closed Friday's trading session at $0.6499, even for the day. The average volume for the last 3 months is 400 and the stock's 52-week low/high is $0.52/$8.98.

Recent News

Prime Harvest Inc.

The QualityStocks Daily Newsletter would like to spotlight Prime Harvest Inc.

Prime Harvest, a technology-driven full-service cannabis corporation, has risen to prominence as a leader in California’s cannabis industry. “Prime Harvest is horizontally diversified across the entire cannabis value chain with business activities focused on direct-to-consumer operations, licensing acquisition, compliance management and state-wide delivery. The company continues to expand its footprint throughout California with a proven long-term strategy of investing in growth and scale of licensed assets while leveraging the power of data-driven technology across its operations,” a recent article reads. “Prime Harvest is backed by a strong business strategy and anchored by its commitment to community, diversity and becoming California’s preferred cannabis retailer. The company’s commitment to accountability is fused throughout its operations as it strives to continue growing financially and providing shareholder value.” To view the full article, visit https://ibn.fm/lc9wg

Prime Harvest Inc., based in San Diego, California, is a technology-focused, full-service cannabis company with horizontally diversified operations spanning various segments of the cannabis value chain, from licensing acquisition and compliance management to direct-to-consumer operations. The company is leveraging a long-term strategy of investing in the growth and scale of licensed assets anchored by the power of data-driven technology to expand its footprint throughout California.

Sustainability is key to Prime Harvest’s corporate vision. The company aims to ensure that the communities it serves capture their fair share of the fruits of the industry’s growth, including financial profit, employment opportunities, environmental enrichment and impactful innovation through R&D and education.

The company’s mission is to appeal to the ethos of the cannabis consumer by setting a new operational standard emphasizing accountability, sustainability and community. With this commitment, Prime Harvest continues to work toward positively affecting millions of lives through the creation of a world-class platform that caters to strengthening the commercial cannabis pipeline.

Jaxx Cannabis

Jaxx Cannabis is the flagship brand in Prime Harvest’s portfolio. Through Jaxx Cannabis, the company aims to use technology to facilitate a true customer-centric culture while enhancing the overall craft cannabis experience. Jaxx features an expertly curated selection of premium products from some of the most respected brands in the thriving California market.

Key values serving as the foundation of Jaxx Cannabis include:

  • Creating and nurturing a welcoming culture for all
  • Unlocking the true potential of customer value
  • Being innovative in uncovering new ways to grow both the company and the industry
  • Meeting the wants and needs of consumers to promote profitability
  • Remaining accountable for the results of its operations

It is these values that differentiate Prime Harvest and Jaxx Cannabis in the California cannabis sector.

Brand Partnerships

Prime Harvest works diligently to establish strong alliances with complementary brands that are in alignment with its culture and values. Through a combination of deliberate foresight and strategic action, the company seeks to grow existing cannabis brands and continuously discover new, high-potential performers that are primed for long-term success.

These partnerships enhance Prime Harvest’s efforts to transform the world’s cannabis access and bring its consumers high-quality products that are fair for both people and the planet.

Responsibility

Prime Harvest remains committed to the goal of creating a more sustainable environment, now and in the future. Concern for human beings and the environment can be observed in every facet of its operations, including its ongoing R&D activities dedicated to exploring methods of reducing and repurposing waste into composite materials and exploring the potential of the hemp plant for industrial and wellness contributions.

The company is a proud member of the Community Alliance Program, a foundation that seeks to make a difference in local communities by providing financial assistance for educational programs, housing homeless veterans, creating urban farms, and holding local arts initiatives for children and adults. The program also helps explore the natural healing attributes of medical cannabis through research, development, clinical trials, and advocating for the safe access of cannabis to those in need.

Market Overview

Ongoing changes in U.S. state government policies toward cannabis are expected to cause demand for legal marijuana to surge. In addition, the number of indications for which medical marijuana is prescribed continues to increase. These factors are expected to rapidly boost legal sales of cannabis products.

Legal sales across the U.S. hit a record of $17.5 billion in 2020, marking an increase of 46% over 2019, according to Forbes. This strong growth is expected to continue. According to a Grand View Research report, the global legal marijuana market is forecast to grow at a CAGR of 26.7 percent from 2021 to 2028.

California – Prime Harvest’s home state – has consistently led the pack in terms of U.S. cannabis sales. The Motley Fool pegged cannabis spending in the Golden State at $3.8 billion in 2020, more than doubling the second state on its list.

Leadership Team

The Prime Harvest team is composed of true experts in their respective fields focused on building a world-class organization capable of driving the cannabis industry and movement forward.

E. Duane Alexander is the company’s Founder and CEO. He brings to the team more than 25 years of real-world, hands-on cannabis retail, marketing and commercial operations experience. Mr. Alexander has championed 40+ cannabis license applications throughout the western U.S. to date.

John Wilczak is the COO of Prime Harvest. He has 30+ years of executive management, strategy development & configuration experience with GE, pharmaceutical and agriculture companies. Mr. Wilczak is a Brown & Columbia MBA with vast knowledge of technology driven intellectual properties.

Andrea Jenson is the Chief Financial Officer of Prime Harvest. As CFO, she is responsible for all the company’s financial functions, including accounting, corporate finance and investor relations. Her career spans more than 20 years of varied experience in financial management, business leadership and financial strategy.

John Kazanjian is the VP of Business Development of Prime Harvest. He has worked over 40 years in business operations, brand marketing, sales and investor/lender communications. Mr. Kazanjian earned his B.S. from Rutgers University and his MBA from Harvard University.

Johann Balbuena is the Chief Marketing Officer of Prime Harvest. She has more than six years of experience in California cannabis licensing acquisition and compliance management. Ms. Balbuena has led multimedia production and content marketing efforts for the likes of the Social Club TV app, The Emerald Cup, High Times, Weedmaps and Synergy.


Recent News

chart

Golden Matrix Group Inc. (NASDAQ: GMGI)

The QualityStocks Daily Newsletter would like to spotlight Golden Matrix Group Inc. (NASDAQ: GMGI).

  • Golden Matrix Group, Inc has been a major beneficiary of the growth in online gaming as well as the ongoing regulation and legalization of online casinos and online sports betting Globally
  • The Company has expanded its white-label B2B offering through the launch of the GM-X and GM-Ag turnkey solution, a complete software package designed to allow land-based operators to transition into providing online operations
  • GMGI have separately sought to bolster their B2C offering, most recently through the acquisition of a controlling stake in UK-based RKingsCompetitions, a leading online competition company in the UK and Northern Ireland
  • In addition to contributing over $5.1 million to GMGI’s top-line revenues in the most recent quarter, RKings’ has also been responsible for providing GMGI with upwards of 45,000 new customers per quarter

In 2006, the United States passed the Unlawful Internet Gaming Enforcement Act, infamously banning all remote gambling in the US overnight. At the time, the law acted seemed like a death knell for the sector. The sector has recently experienced a rebirth following the Supreme Court’s decision in 2018 to repeal the Professional and Amateur Sports Protection Act (“PASPA”) – clearing the way for legalized sports bettering across the nation. In just four years, the industry has worked itself into the daily lives of millions of Americans and today most major countries in the world have rules regulating online gambling rather than banning the activity. The global online gambling market size is expected to reach USD 153.6 billion by 2030, registering a CAGR of 11.7% from 2022 to 2030, according to a new report by Grand View Research, Inc. Amongst the beneficiaries was Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms and systems and a portfolio of over 10,000 third party games. Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, made its foray into the business-to-consumer (“B2C”) marketplace in December following the acquisition of an 80% stake in RKings Competitions Ltd. RKings is a United Kingdom-based company and leading operator of online skill-based competitions throughout the U.K. and Ireland. A recent article reads: “Less than six months into its ownership, Golden Matrix gave RKings a robust upgrade, launching the tournament platform with added features and functionality. Expectations are that the new platform will increase both the monthly number of skill tournaments and participants, thus generating even stronger revenue and profit from RKings’ prize competition business… ‘This significant upgrade to the RKings platform will accelerate the growth of our B2C businesses, offering added functionality and features and also allowing us to expand into new geographic regions and strengthen our global footprint,’ said Golden Matrix CEO Brian Goodman... In its recent press release on the RKings upgrade, Golden Matrix noted that the expansion into B2C has made an immediate impact on the top and bottom lines in the first half of fiscal 2022 (ended April 30, 2022).” To view the full article, visit https://ibn.fm/3T1fi.

Golden Matrix Group Inc. (NASDAQ: GMGI), based in Las Vegas, Nevada, is an established gaming technology company that develops and owns online gaming IP and builds turnkey online casino solutions for gaming operators as well as configurable and scalable white-label gaming platforms for international customers, located primarily in the Asia-Pacific region. GMGI’s gaming IP includes tools for marketing, acquisition, retention and monetization of users. The company’s platform can be accessed through both desktop and mobile applications.

GMGI’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with U.S. law.

Golden Matrix, through a subsidiary, also runs a pay-to-enter prize competition in the United Kingdom and Ireland.

The company’s shares began trading on the Nasdaq under the symbol ‘GMGI’ on March 17, 2022. Golden Matrix shares were previously traded on the OTCQX Best Market.

For the quarter ended January 31, 2022, the company reported revenue of $8.88 million, an increase of 355% over the same quarter one year earlier. Net income for the three-month period was $349,379, up from $52,158 a year earlier. It was the company’s 14th consecutive profitable quarter.

In December 2021, Golden Matrix announced it had entered into a purchase agreement to acquire a controlling ownership interest in UK-based RKingsCompetitions Ltd., one of Ireland’s and the United Kingdom’s leading independent online competition companies. RKings presents customers with paid and free entry routes to competitions that offer a range of prizes, including residential properties, luxury and exotic motor vehicles, holiday packages, technology packages and cash. The competitions are currently open only to residents of Ireland and the United Kingdom. Golden Matrix acquired an 80% ownership interest in RKings for cash and stock. The company also secured an option to purchase the remaining 20 percent interest of RKings, subject to certain requirements.

In March 2022, Golden Matrix announced it had applied for a Mexican gaming permit and, once approved, expects to offer online gaming in Mexico as well as roll out the RKings tournament business globally.

Technology

Golden Matrix Group develops fully operational online casino turnkey solutions as well as highly modular, configurable and scalable gaming platforms for its international customers in an effort to promote user acquisition, engagement, retention and monetization. The provided white label gaming platform is unparalleled in both mobile and desktop website deployment, proving compatible throughout all major operating systems and web browsers. In addition, the platform enhances the client’s ability to cater to various gaming scenarios including but not limited to transaction management and a range of loyalty and reward programs. Moreover, user engagement is optimized through the ability to accommodate both free and paid games.

The company’s GM-X System (and recently its next generation GM-Ag System) is considered the industry standard, granting access to over 10,000 games from more than 25 game providers. Through the GM-X System, Golden Matrix offers the industry’s most extensive game portfolio. The company’s gaming partners dominate the global online gaming market to deliver innovative games and premium brand titles. The GM-X System offers payment gateways that integrate with third party platforms or digital wallets. It supports all major currencies and offers multiple language options. The system’s data analytics provide the operator with a 360-degree view of the gaming platform’s performance.

GMGI currently supports over 500 unique casino brands and over 6 million players.

Market Outlook

Online gaming and sports betting sites and apps are increasingly taking market share from traditional location-based casinos. Widespread internet service availability and increasing use of mobile phones for playing online games from homes and public places is driving the market, according to a report from Grand View Research. In addition, factors such as easy access to online gambling, legalization and cultural approval, corporate sponsorships, and celebrity endorsements are also contributing to market growth. The growing availability of cost-effective mobile applications across the globe is further expected to fuel market growth.

This trend is only expected to accelerate as millennials reach their peak earning years and Gen Z youth begin to complete their education and move into careers. These generations are completely comfortable with online recreation, and with using technology like digital wallets and digital gameplay that underpins online gaming.

The global online gambling market was valued at $53.7 billion in 2019 and is expected to grow at a CAGR of 11.5% from 2020 to 2027 to reach a value of $127.3 billion, according to Grand View Research, with much of the growth expected from the U.S. and Asia. Even Europe, the most mature gaming market, is expected to grow at a rate of 20-25% year-over-year.

Management Team

Brian Goodman is CEO of Golden Matrix Group. He has more than 20 years of diverse senior management experience and business development roles within the technology and internet gaming industries. He has a tertiary science qualification as well as a marketing and sales background. His previous roles have been entrepreneurial and include CEO and senior management positions in smaller organizations, which he founded or in which he held equity, as well as multinational organizations.

Cathy Feng is COO at Golden Matrix. She is a co-founder of GMGI and holds a Master of Commerce degree. She has 10 years of experience as a financial officer in the technology and internet gaming industries. In past management positions, she interpreted, analyzed and presented financial and operation information to facilitate business decisions, grow companies and resolve complex problems. In addition, she has skills in marketing, business development, leadership and strategic planning.

Omar Jimenez is CFO and Chief Compliance Officer at GMGI. Prior to joining the company, he was CFO and COO of Alfadan Inc., a supplier of marine outboard engines. He has held senior financial management and operational positions at public and private companies including NextPlay Technologies, American Leisure Holdings, US Installation Group and Onyx Group. He holds various accounting professional certifications, including CPA and CPCU, and degrees in finance, accounting and business.

Henry Zhang is Chief Technology Officer at Golden Matrix. He oversees all aspects of development, integration and deployment of GMGI’s technology systems. He plays a key role in evolving GMGI’s technology business to lead and shape the industry. He is responsible for developing and scaling new businesses, including online gaming, eSport and P2P Systems. He was instrumental in launching the GM-X system and has been with the company for more than six years.

Golden Matrix Group Inc. (NASDAQ: GMGI), closed Friday's trading session at $4.84, off by 2.0243%, on 719,371 volume. The average volume for the last 3 months is 719,371 and the stock's 52-week low/high is $3.29/$10.72.

Recent News

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF)

The QualityStocks Daily Newsletter would like to spotlight Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF).

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0), a publicly-traded investment company, today released its first quarter 2022 financial results. Among the highlights, the company reported an 8.6% growth in assets to $64,769,938 at Feb. 28, 2022, from $59,627,414 at Nov. 30, 2021. The company also noted an improved cash position to $5,552,018 at Feb. 28, 2022, from $545,976 at Nov. 30, 2021. In addition, Eat Well Group provided several portfolio company highlights, including reported revenue of $12,809,752 and gross profit of $2,072,824 for Belle Pulses in Q1, as well as Sapientia’s commercialization of intellectual property and launch of white label better-for-you plant-based twisted curls. The update also addressed expansion of Amara Organic Foods’ products, adding to an already robust eCommerce and brick-and-mortar distribution network. “At a time when global/ macro trends have placed a tremendous importance on food production and alternative protein supply, our investments are not only proving to be timely but are contributors to global food security solutions,” said Marc Aneed, the company’s president and CEO. “With the majority of transaction costs behind us, we can now focus on attracting significant new capital partners, refinancing debt, and helping scale our portfolio companies.” To view the full press release, visit https://ibn.fm/POiIK

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF), headquartered in Vancouver, British Columbia, is a publicly traded vertically integrated plant-based foods company combining the best of agribusiness, foodtech, and CPG brands to supply the world with innovative, delicious, and better-for-you foods. The company supplies Beyond Meat, Ingredion, Nestle, General Mills and more. It is on track to generate $60 million in revenue for 2021 and is projecting $100 million in revenue for 2022.

Eat Well’s management team has an extensive record of sourcing, financing and building successful companies across a broad range of industries and maintains a current investment mandate on the health and wellness industry. The team has financed and invested in early-stage venture companies for more than 25 years, resulting in the ability to construct a portfolio of opportunistic investments intended to generate superior risk-adjusted returns. Eat Well’s strategic advisory board includes pioneers in the plant-based foods industry, including HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, and Jeff Dunn, CEO of Bolthouse Farms who previously held senior leadership positions at both Campbell Soup Company and The Coca Cola Company.

The company’s plant-based investment thesis is centered on growing its seed-to-market operations, which include raw ingredients, processing, pulse fractionation, unique IP and premium consumer packaged goods (CPG). Eat Well Group is building a unique ecosystem that can supply these essential cornerstone needs for society. The company has plant-based foods and nutrition experts specializing in the latest science and original thinking for what consumers want most – high quality and affordability in healthy, clean and simple products.

Eat Well focuses on intellectual property, product portfolio development and long-term value creation for stakeholders in a rapidly expanding industry. As an emergent sector globally, plant-based foods represent a double-digit annual growth category, with more than 35% of the world’s supply of pulse proteins coming from Canada.

Portfolio

On July 31, 2021, Eat Well Group acquired Belle Pulses Ltd., one of the top pulse processors in Canada. Belle Pulses has been operating for over 40 years and had over $60 million in sales in 2020. The company counts a broad range of customers in over 35 countries, including global strategic food companies and major ingredient distributors. Currently, Belle produces nearly 100,000 tons of fully traceable seed and product, yielding over 26,000 tons of pure plant protein.

Eat Well also owns 100% of Sapientia Technology Inc. Led by Dr. Eugenio Bortone – one of the world’s preeminent food scientists and extrusion processing experts and the inventor of Frito-Lay’s Twisted Cheetos – Sapientia has filed four patents around the “protein curl” and crispy-puff-style snack. By focusing on texture and crunch, Sapientia’s patents solve one of the major problems that large scale snack food companies have struggled with for years – how to offer appealing texture and flavor in a guilt-free, not fried, natural and healthy alternative to the majority of snack food products available today.

Eat Well owns a 51% share of Amara Organic Foods, with an option to acquire additional ownership up to 80 percent. Amara, one of the fastest-growing baby food brands in America, is a food technology company that uses science and proprietary IP that locks in taste and texture to make healthy, organic, non-GMO, plant-based, convenient baby and children’s food possible for modern-day families. From baby food to toddler food and beyond, Amara is driven by the belief that setting kids on the right path from a young age will help them live better, feel better and think better for the rest of their lives. Amara’s revenues have grown by more than 400% since January 2021, and the brand’s success has drawn media coverage from business news outlets including Forbes and TechCrunch.

Market Outlook

According to an August 2021 report from Bloomberg Intelligence, the plant-based foods market is expected to experience explosive growth, comprising up to 7.7% of the global protein market by 2030 at a value of over $162 billion, up from $29.4 billion in 2020. Bloomberg notes that plant-based alternatives are here to stay, and that consumption will grow rapidly. Plant-based food sales in 2020 grew twice as fast as overall food sales, according to Polaris Market Research.

Pulse proteins (fava, yellow pea, etc.) are a foundational ingredient to most plant-based foods due to their high protein content and their readily available, affordable supply.

Many analysts view the food tech market as similar to the early days of the Internet in that plant-based foods represent a worldwide secular trend of steady growth and potential that will revolutionize the way society functions and people experience nutrition.

The sector continues to experience significant M&A transactions. Recently, Sol Cuisine was acquired by PlantPlus Foods LLC, a major South American protein producer, in an all-cash transaction valued at approximately $126 million, or 6x revenue.

Management Team

Marc Aneed is President and Director of Eat Well Group. His 20-year career in CPG started at The Quaker Oats Company/PepsiCo, where he worked on iconic brands like Gatorade. He previously was at Glanbia PLC, a global nutrition company, where he led Amazing Grass, a leading plant nutrition and supplement company with over $100 million in retail sales. He also led Glanbia’s Sports Nutrition brands in North America with over $750 million in retail sales. Mr. Aneed has launched dozens of successful consumer products, driving over $1 billion in collective retail sales.

Mark Coles is the company’s Chief Investment Officer. He is a veteran CPG senior executive specializing in the plant-based foods sector. For the past decade, Mr. Coles has spearheaded global plant-based start-up initiatives, culminating in a 2020 acquisition by an international New York Stock Exchange-listed food ingredient company. He has over 25 years of experience in CPG-focused strategy, mergers and acquisitions and project financing.

Patrick Dunn is Eat Well Group’s Vice President, Finance. He is the founding partner of Dunn, Pariser & Peyrot and has a track record of building highly successful agribusinesses throughout North America and other international markets. As a testimony to his business portfolio work, Mr. Dunn and his firm have won multiple industry awards for accounting, finance and business management.

Barry Didato is the company’s Vice President, Strategy. He is focused on the development of strategic revenue channels, sales partnerships, and international distribution for Eat Well Group. Mr. Didato brings extensive strategic sales capabilities and an extensive network of contacts in the industry to the company. Prior to joining Eat Well Group, he served for over 18 years as a senior advisor for several ultra-high net worth family offices and numerous innovative wellness, nutrition, medical, and food businesses.

Strategic Advisory Board

HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, is a firm supporter of clean energy and the humane treatment of animals. He is also a vocal supporter of the private sector in the Middle East. A member of the Saudi Arabian Royal Family, Prince Khaled was born in Stanford and spent his youth in Riyadh under the mentorship of his father, philanthropist HRH Prince Alwaleed bin Talal Al Saud, Chairman of Kingdom Holding Company. He is also the Founding Chairman of KBW Investments and serves across several boards. He invests in an array of successful but diverse global businesses – from promising technology startups to established companies. Today, with holdings on three continents, Prince Khaled stands at the gateway between the Middle East’s evolving economies and the Western world. Consistently, Prince Khaled’s focus is on ventures and ideas at the intersection of innovation and economic growth.

Jeff Dunn has over 30 years of experience in agriculture and packaged food, including senior leadership positions with Bolthouse Farms, Campbell Soup Company and The Coca Cola Company, among others. He is an Operating Partner at Butterfly and focuses primarily on the agriculture & aquaculture and food & beverage product sectors. Prior to joining Butterfly, Mr. Dunn was the President of the Campbell Fresh division of Campbell Soup Company from 2015 to 2016, where he was in charge of building Campbell’s scale and accelerating its growth in the rapidly expanding packaged fresh segments and categories across the retail perimeter.

Eat Well Investment Group Inc. (OTC: EWGFF), closed Friday's trading session at $0.1712, off by 9.3028%, on 12,900 volume. The average volume for the last 3 months is 12,900 and the stock's 52-week low/high is $0.1712/$1.00.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

The coronavirus pandemic besieged the world for more than two years, forcing countries around the globe to shut down and quarantine in a bid to halt the spread of the virus. Nearly two and a half years after authorities in Wuhan, China, reported the outbreak of a novel coronavirus, the world is starting to emerge from the pandemic. Governments have been lifting lockdown restrictions and mask mandates for the past couple of months, allowing their residents to finally get out of their homes after months and months of isolation. However, the coronavirus pandemic and the subsequent lockdowns seem to have had a peculiar effect. These reemerging viral infections make a strong case justifying why entities such as AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) continue to invest heavily into discovery programs aimed at finding clinical solutions to any complexities that are caused by various viral diseases.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.

Products

Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.

Containers

ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Friday's trading session at $0.0899, off by 30.3101%, on 2,015 volume. The average volume for the last 3 months is 2,015 and the stock's 52-week low/high is $0.054/$0.32616.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.